Global Clinical Trials
Private Company
Funding information not available
Overview
Global Clinical Trials is a well-established, privately-held CRO with over 25 years of operational history, offering comprehensive clinical research services globally. It has built a strong track record with over 400 completed trials, a focus on therapeutic areas like oncology and CNS, and a client base that includes top-10 pharmaceutical companies. The company differentiates itself through deep regional expertise in emerging markets across Eastern Europe and Asia, competitive pricing, and a high rate of repeat business, supported by a team of over 100 full-time employees.
Technology Platform
Integrated clinical trial service delivery model leveraging deep local regulatory and operational expertise in the USA, Europe (especially Eastern Europe), and Asia. Utilizes standard industry systems for data management, safety, and operations within an ICH-GCP compliant framework.
Opportunities
Risk Factors
Competitive Landscape
GCT competes in the highly fragmented global CRO market, facing giants like IQVIA, ICON, and Parexel, as well as numerous niche and regional players. Its primary competitive differentiation is its deep, established local expertise in emerging European and Asian markets, offering sponsors a blend of global standards and regional efficiency that larger CROs may not match in agility.